Medical device maker DJO Global, Inc. announced that its executive vice president of U.S. commercial operations, Andrew Holman, will leave the company “to pursue other opportunities.”
Newly minted DJO president & CEO Mike Mogul will assume responsibility for the San Diego, Calif.-based company’s U.S. commercial activities.
"In the three months since I joined DJO, I have become increasingly optimistic about the depth and breadth of opportunities available to add value to our customers and to accelerate DJO’s revenue growth," said Mogul in prepared remarks.
Mogul, the former head of Stryker Corp.’s (NYSE:SYK) $4-billion-plus orthopedics division, joined DJO Global in June.
Holman is a device veteran himself, with a pedigree that includes stints at Boston Scientific (NYSE:BSX), Johnson & Johnson (NYSE:JNJ) and Smith & Nephew (NYSE:SNN), including president for North & South America of Smith & Nephew Orthopaedics.
Here’s the latest personnel changes from medical device, diagnostics and life science companies around the nation. For more recent hirings and firings, check out MassDevice’s compilation of the latest personnel moves.
- National Institute of Environmental Health Sciences names new scientific director
- Biogen replaces its head of commercial operations
- Revolutions Medical’s president resigns his post
- Sanuwave elects Barbara Henagan to board of directors
- Stereotaxis appoints new CFO
- Edwards named Novella’s VP of European Operations
- Elekta appoints Wai executive VP of Asia Pacific region
- Coronado Biosciences names a new executive VP & chief operating officer
- Dehaier Medical appoints interim CFO